divalproex sodium
NDC 0615-8587, divalproex sodium, tablet, delayed release, from NCS HealthCare of KY, LLC dba Vangard Labs.
- Product NDC
- 0615-8587
- Status
- Listed
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078853
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0615-8587 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIVALPROEX SODIUM250 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0615-8587-39 | 00615858739 | 30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-8587-39) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f936b9d0-a58f-4fa5-8db9-752dabb837a6
Use it
Look up 0615-8587 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0615-8587 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0615-8587. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.